The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Growth of the Stress-Bearing and Shape-Maintaining Murein Sacculus of Escherichia coli
Höltje, J.-V. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.181-203.1998 · Cited by 1,129
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Self-citationGenetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
Self-citationWiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 790
Self-citationLipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Bacterial Cell Wall Synthesis: New Insights from Localization Studies
Scheffers, D.-J., & Pinho, M. G. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.585-607.2005 · Cited by 629
Lantibiotics: Peptides of Diverse Structure and Function
Willey, J. M., & van der Donk, W. A. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093501 · Cited by 621
Errington, J., Daniel, R. A., & Scheffers, D.-J. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.1.52-65.2003 · Cited by 599
Hsu, S.-T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., Bonvin, A. M. J. J., & van Nuland, N. A. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb830 · Cited by 547
Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
Bierbaum, G., & Sahl, H.-G. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048616 · Cited by 524
Self-citationDysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Self-citationAn Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Sahl, H.-G., & Bierbaum, G. (1998) · Annual Review of Microbiology · doi:10.1146/annurev.micro.52.1.41 · Cited by 476
Self-citationAn Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
Haydon, D. J., Stokes, N. R., Ure, R., Galbraith, G., Bennett, J. M., Brown, D. R., Baker, P. J., Barynin, V. V., Rice, D. W., Sedelnikova, S. E., et al. (2008) · Science · doi:10.1126/science.1159961 · Cited by 452
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
Brötz, H., Josten, M., Wiedemann, I., Schneider, U., Götz, F., Bierbaum, G., & Sahl, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01065.x · Cited by 421
Self-citationNatural products to drugs: daptomycin and related lipopeptide antibiotics
Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Appelbaum, P. C. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01344.x · Cited by 376
Structural Insight into the Transglycosylation Step of Bacterial Cell-Wall Biosynthesis
Lovering, A. L., de Castro, L. H., Lim, D., & Strynadka, N. C. J. (2007) · Science · doi:10.1126/science.1136611 · Cited by 306
Structural Transitions as Determinants of the Action of the Calcium-Dependent Antibiotic Daptomycin
Jung, D., Rozek, A., Okon, M., & Hancock, R. E. W. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.020 · Cited by 297
Wiedemann, I., Böttiger, T., Bonelli, R. R., Wiese, A., Hagge, S. O., Gutsmann, T., Seydel, U., Deegan, L., Hill, C., Ross, P., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05223.x · Cited by 222
Self-citationDaptomycin disrupts membrane potential in growing Staphylococcus aureus
Alborn, W. E., Allen, N. E., & Preston, D. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2282 · Cited by 213
Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., & Wilkinson, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01121-07 · Cited by 205
Bierbaum, G., & Sahl, H. G. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5452-5458.1987 · Cited by 191
Self-citationSchneider, T., Senn, M. M., Berger‐Bächi, B., Tossi, A., Sahl, H., & Wiedemann, I. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04149.x · Cited by 183
Self-citationLipid II-Mediated Pore Formation by the Peptide Antibiotic Nisin: a Black Lipid Membrane Study
Wiedemann, I., Benz, R., & Sahl, H.-G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.10.3259-3261.2004 · Cited by 182
Self-citationSchneider, T., Gries, K., Josten, M., Wiedemann, I., Pelzer, S., Labischinski, H., & Sahl, H.-G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01040-08 · Cited by 181
Self-citationBacitracin sensing in Bacillus subtilis
Rietkötter, E., Hoyer, D., & Mascher, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06194.x · Cited by 173
Pinho, M. G., & Errington, J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04420.x · Cited by 168
The prokaryotic cytoskeleton: a putative target for inhibitors and antibiotics?
Vollmer, W. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0586-0 · Cited by 153
Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032
Allen, N. E., Hobbs, J. N., & Alborn, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1093 · Cited by 151
The bacterial envelope as a target for novel anti-MRSA antibiotics
Françoise Van Bambeke, A., Mingeot‐Leclercq, M., Struelens, M. J., & Tulkens, P. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.004 · Cited by 149
Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
Kim, S. J., Cegelski, L., Stueber, D., Singh, M., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.031 · Cited by 134
Ghachi, M. E., Bouhss, A., Barreteau, H., Touzé, T., Auger, G., Blanot, D., & Mengin‐Lecreulx, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602834200 · Cited by 126
NMR Study of Mersacidin and Lipid II Interaction in Dodecylphosphocholine Micelles
Hsu, S. D., Breukink, E. J., Bierbaum, G., Sahl, H., KRUIJFF, B. D., Kaptein, R., van Nuland, N. A. J., & Bonvin, A. M. J. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211144200 · Cited by 125
Self-citationCamargo, I. L. B. D. C., Neoh, H., Cui, L., & Hiramatsu, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00417-08 · Cited by 121
Lipid spirals in Bacillus subtilis and their role in cell division
Barák, I., Muchová, K., Wilkinson, A. J., O’Toole, P. J., & Pavlendová, N. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06236.x · Cited by 117
Martı́nez, B., Böttiger, T., Schneider, T., Rodrı́guez, A., Sahl, H., & Wiedemann, I. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00092-08 · Cited by 108
Self-citationThe Targets of Currently Used Antibacterial Agents: Lessons for Drug Discovery
Lange, R., Locher, H. H., Wyss, P. C., et al. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782110408 · Cited by 107
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model
Kokai‐Kun, J. F., Chanturiya, T., & Mond, J. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm347 · Cited by 98
Henrichfreise, B., Schiefer, A., Schneider, T., Nzukou, E., Poellinger, C., Hoffmann, T., Johnston, K. L., Mölleken, K., Wiedemann, I., Pfarr, K. M., et al. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06815.x · Cited by 86
Self-citationBacteriophage and Peptidoglycan Degrading Enzymes with Antimicrobial Applications
Donovan, D. M. (2007) · Recent Patents on Biotechnology · doi:10.2174/187220807780809463 · Cited by 84
Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C
Wiedemann, I., Böttiger, T., Bonelli, R. R., Schneider, T., Sahl, H., & Martı́nez, B. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2809-2814.2006 · Cited by 84
Self-citationPag, U., Oedenkoven, M., Sass, V., Shai, Y., Валерьевна, Ш. О., Antcheva, N., Tossi, A., & Sahl, H. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm479 · Cited by 79
Self-citationWecke, T., Zühlke, D., Mäder, U., Jordan, S., Voigt, B., Pelzer, S., Labischinski, H., Homuth, G., Hecker, M., & Mascher, T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01046-08 · Cited by 77
Sass, V., Pag, U., Tossi, A., Bierbaum, G., & Sahl, H. (2008) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2008.01.011 · Cited by 74
Self-citationBambeke, F. V. (2006) · PubMed · Cited by 73
Inhibition of peptidoglycan biosynthesis in Bacillus megaterium by daptomycin
Mengin‐Lecreulx, D., Allen, N. E., Hobbs, J. N., & Heijenoort, J. (1990) · FEMS Microbiology Letters · doi:10.1016/0378-1097(90)90074-z · Cited by 43
Vancomycin resistance: are there better glycopeptides coming?
Linden, P. K. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.917 · Cited by 23
Cited by
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Self-citationChallenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., & Bezirtzoglou, E. (2021) · Microorganisms · doi:10.3390/microorganisms9102041 · Cited by 993
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Boron Containing Compounds as Protease Inhibitors
Smoum, R., Rubinstein, A., Dembitsky, V. M., & Srebnik, M. (2012) · Chemical Reviews · doi:10.1021/cr608202m · Cited by 450
Metadata
- Authors
- Schneider, T., & Sahl, H.-G.
- Venue
- International Journal of Medical Microbiology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 300
- Issue
- 2-3
- Pages
- 161-169
- ISSN
- 1438-4221 (ISSN-L)
- OpenAlex
- W1977377333
- Cited by
- 261
- References
- 54
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.